Healthcare -
Biotechnology - NASDAQ - US
$ 13.61
3.34 %
$ 1.54 B
Market Cap
-4.04
P/E
Price Target
Average
242.58%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
25.99%
Net Income
Estimate
33.55%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Dyne Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for DYN of $46.6 , with forecasts ranging from
a
low of
$40 to a high of $55 .
DYN Lowest Price Target
Wall Street Target
40 USD
193.90%
DYN Average Price Target
Wall Street Target
46.6 USD
242.58%
DYN Highest Price Target
Wall Street Target
55 USD
304.11%
REVENUE FORECAST
Revenue Forecast Chart DYN
EBIT FORECAST
EBIT Forecast Chart DYN
NET INCOME FORECAST
Net Income Chart DYN